Bleeding Risk With Apixaban Versus Rivaroxaban in Acute Pulmonary Embolism

Clinical trial NCT07774273 · COMPLETED

Trial details

NCT number: NCT07774273
Sponsor: Combined military hospital lahore
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pulmonary Embolism Acute Venous Thromboembolism (VTE)

Start date: 2021-01-01
Primary completion: 2025-12-31
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.